Overall survival of metastatic melanoma patients treated with HD IL-2 followed by immune checkpoint blockade of the CTLA-4 or the PD-1 pathways: analysis of data on the current use of HD IL-2

Detalles Bibliográficos
Autores principales: Wong, Michael KK, Morse, Michael A, McDermott, David F, Clark, Joseph I, Kaufman, Howard L, Daniels, Gregory A, Perritt, Jessica C, Hua, Hong, Aung, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649297/
http://dx.doi.org/10.1186/2051-1426-3-S2-P359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649297/
http://dx.doi.org/10.1186/2051-1426-3-S2-P359

Ejemplares similares